These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 29775144)
1. The economic consequences of neurosurgical disease in low- and middle-income countries. Rudolfson N; Dewan MC; Park KB; Shrime MG; Meara JG; Alkire BC J Neurosurg; 2019 Apr; 130(4):1149-1156. PubMed ID: 29775144 [TBL] [Abstract][Full Text] [Related]
2. Global economic consequences of selected surgical diseases: a modelling study. Alkire BC; Shrime MG; Dare AJ; Vincent JR; Meara JG Lancet Glob Health; 2015 Apr; 3 Suppl 2(Suppl 2):S21-7. PubMed ID: 25926317 [TBL] [Abstract][Full Text] [Related]
3. Global macroeconomic burden of epilepsy and the role for neurosurgery: a modelling study based upon the 2016 Global Burden of Disease data. O'Donohoe TJ; Choudhury A; Callander E Eur J Neurol; 2020 Feb; 27(2):360-368. PubMed ID: 31549472 [TBL] [Abstract][Full Text] [Related]
5. The Economic Consequences Of Mortality Amenable To High-Quality Health Care In Low- And Middle-Income Countries. Alkire BC; Peters AW; Shrime MG; Meara JG Health Aff (Millwood); 2018 Jun; 37(6):988-996. PubMed ID: 29863936 [TBL] [Abstract][Full Text] [Related]
6. Global health burden and cost of lead exposure in children and adults: a health impact and economic modelling analysis. Larsen B; Sánchez-Triana E Lancet Planet Health; 2023 Oct; 7(10):e831-e840. PubMed ID: 37714172 [TBL] [Abstract][Full Text] [Related]
7. Economic costs of childhood stunting to the private sector in low- and middle-income countries. Akseer N; Tasic H; Nnachebe Onah M; Wigle J; Rajakumar R; Sanchez-Hernandez D; Akuoku J; Black RE; Horta BL; Nwuneli N; Shine R; Wazny K; Japra N; Shekar M; Hoddinott J EClinicalMedicine; 2022 Mar; 45():101320. PubMed ID: 35308896 [TBL] [Abstract][Full Text] [Related]
8. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050. Global Burden of Disease Health Financing Collaborator Network Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984 [TBL] [Abstract][Full Text] [Related]
9. Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study. Silva S; Ayoub HH; Johnston C; Atun R; Abu-Raddad LJ PLoS Med; 2022 Dec; 19(12):e1003938. PubMed ID: 36520853 [TBL] [Abstract][Full Text] [Related]
10. Head and neck cancer in South Asia: macroeconomic consequences and the role of surgery. Alkire BC; Bergmark RW; Chambers K; Cheney ML; Meara JG Lancet; 2015 Apr; 385 Suppl 2():S56. PubMed ID: 26313106 [TBL] [Abstract][Full Text] [Related]
11. Macroeconomic costs of the unmet burden of surgical disease in Sierra Leone: a retrospective economic analysis. Grimes CE; Quaife M; Kamara TB; Lavy CBD; Leather AJM; Bolkan HA BMJ Open; 2018 Mar; 8(3):e017824. PubMed ID: 29540407 [TBL] [Abstract][Full Text] [Related]
12. Population ageing and deaths attributable to ambient PM Yin H; Brauer M; Zhang JJ; Cai W; Navrud S; Burnett R; Howard C; Deng Z; Kammen DM; Schellnhuber HJ; Chen K; Kan H; Chen ZM; Chen B; Zhang N; Mi Z; Coffman D; Cohen AJ; Guan D; Zhang Q; Gong P; Liu Z Lancet Planet Health; 2021 Jun; 5(6):e356-e367. PubMed ID: 34119010 [TBL] [Abstract][Full Text] [Related]
13. Potential productivity loss from uncorrected and under-corrected presbyopia in low- and middle-income countries: A life table modeling study. Ma Q; Chen M; Li D; Zhou R; Du Y; Yin S; Chen B; Wang H; Jiang J; Guan Z; Qiu K Front Public Health; 2022; 10():983423. PubMed ID: 36304252 [TBL] [Abstract][Full Text] [Related]
14. The Global Macroeconomic Burden of Burn Injuries. Gerstl JVE; Ehsan AN; Lassarén P; Yearley A; Raykar NP; Anderson GA; Smith TR; Sabapathy SR; Ranganathan K Plast Reconstr Surg; 2024 Mar; 153(3):743-752. PubMed ID: 37093034 [TBL] [Abstract][Full Text] [Related]
15. The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030. Schofield D; Shrestha RN; Cunich MM; Passey ME; Veerman L; Tanton R; Kelly SJ BMJ Open; 2017 Jan; 7(1):e013158. PubMed ID: 28069621 [TBL] [Abstract][Full Text] [Related]
16. The Macroeconomic Consequences Of Firearm-Related Fatalities In OECD Countries, 2018-30: A Value-Of-Lost-Output Analysis. Peters AW; Yorlets RR; Shrime MG; Alkire BC Health Aff (Millwood); 2020 Nov; 39(11):1961-1969. PubMed ID: 33136496 [TBL] [Abstract][Full Text] [Related]
17. Global economic cost of smoking-attributable diseases. Goodchild M; Nargis N; Tursan d'Espaignet E Tob Control; 2018 Jan; 27(1):58-64. PubMed ID: 28138063 [TBL] [Abstract][Full Text] [Related]
18. Economic costs of childhood lead exposure in low- and middle-income countries. Attina TM; Trasande L Environ Health Perspect; 2013 Sep; 121(9):1097-102. PubMed ID: 23797342 [TBL] [Abstract][Full Text] [Related]
19. A national stratification of the global macroeconomic burden of central nervous system cancer. Gerstl JVE; Yearley AG; Kilgallon JL; Lassarén P; Robertson FC; Herdell V; Wang AY; Segar DJ; Bernstock JD; Laws ER; Ranganathan K; Smith TR J Neurosurg; 2023 Jun; 138(6):1522-1530. PubMed ID: 36272121 [TBL] [Abstract][Full Text] [Related]
20. Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach. Nandi A; Counts N; Chen S; Seligman B; Tortorice D; Vigo D; Bloom DE EClinicalMedicine; 2022 Sep; 51():101580. PubMed ID: 35898316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]